[1] MICHAIL S,LIN M,FREY M R,et al.Altered gut microbial energy and metabolism in children with non-alcoholic fatty liver disease[J].FEMS Microbiology Ecology,2015,91(2):1-9.
[2] GRUNDY S M.Metabolic syndrome update[J].Trends in Cardiovascular Medicine,2016,26(4):364-373.
[3] ANSTEE Q M,MANTOVANI A,TILG H,et al.Risk of cardiomyopathy and cardiac arrhythmias in patients with nonalcoholic fatty liver disease[J].Nature Reviews Gastroenterology & Hepatology,2018,15(7):425-439.
[4] CHIANG J Y L,FERRELL J M.Bile acids as metabolic regulators and nutrient sensors[J].Annual Review of Nutrition,2019,39:175-200.
[5] DUMASWALA R,BERKOWITZ D,HEUBI J E.Adaptive response of the enterohepatic circulation of bile acids to extrahepatic cholestasis[J].Hepatology,1996,23(3):623-629.
[6] JADHAV K,XU Y,XU Y Y,et al.Reversal of metabolic disorders by pharmacological activation of bile acid receptors TGR5 and FXR[J].Molecular Metabolism,2018,9:131-140.
[7] MOLINARO A,WAHLSTRÖM A,MARSCHALL H U.Role of bile acids in metabolic control[J].Trends in Endocrinology & Metabolism,2018,29(1):31-41.
[8] MAKISHIMA M,LU T T,XIE W,et al.Vitamin D receptor as an intestinal bile acid sensor[J].Science,2002,296(5571):1313-1316.
[9] GOODWIN B,GAUTHIER K C,UMETANI M,et al.Identification of bile acid precursors as endogenous ligands for the nuclear xenobiotic pregnane X receptor[J].Proceedings of the National Academy of Sciences of the United States of America,2003,100(1):223-228.
[10] DI CIAULA A,GARRUTI G,BACCETTO R L,et al.Bile acid physiology[J].Annals of Hepatology,2017,16(Suppl.1):S4-S14.
[11] KAUR A,PATANKAR J V,DE HAAN W,et al.Loss of
Cyp8b1 improves glucose homeostasis by increasing GLP-1[J].Diabetes,2015,64(4):1168-1179.
[12] PATHAK P,XIE C,NICHOLS R G,et al.Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism[J].Hepatology,2018,68(4):1574-1588.
[13] LEGRY V,FRANCQUE S,HAAS J T,et al.Bile acid alterations are associated with insulin resistance,but not with NASH,in obese subjects[J].The Journal of Clinical Endocrinology & Metabolism,2017,102(10):3783-3794.
[14] APPLEBY R N,MOGHUL I,KHAN S,et al.Non-alcoholic fatty liver disease is associated with dysregulated bile acid synthesis and diarrhea:a prospective observational study[J].PLoS One,2019,14(1):e0211348.
[15] QI X Y,YUN C Y,SUN L L,et al.Gut microbiota-bile acid-interleukin-22 axis orchestrates polycystic ovary syndrome[J].Nature Medicine,2019,25(8):1225-1233.
[16] FALANY C N,FORTINBERRY H,LEITER E H,et al.Cloning,expression,and chromosomal localization of mouse liver bile acid CoA:amino acid N-acyltransferase[J].The Journal of Lipid Research,1997,38(6):1139-1148.
[17] ALREFAI W A,GILL R K.Bile acid transporters:structure,function,regulation and pathophysiological implications[J].Pharmaceutical Research,2007,24(10):1803-1823.
[18] GARCÍA-CAÑAVERAS J C,DONATO M T,CASTELL J V,et al.Targeted profiling of circulating and hepatic bile acids in human,mouse,and rat using a UPLC-MRM-MS-validated method[J].The Journal of Lipid Research,2012,53(10):2231-2241.
[19] ZHANG L,WU W D,LEE Y K,et al.Spatial heterogeneity and co-occurrence of mucosal and luminal microbiome across swine intestinal tract[J].Frontiers in Microbiology,2018,9:48.
[20] KOSTERS A,KARPEN S J.Bile acid transporters in health and disease[J].Xenobiotica,2008,38(7/8):1043-1071.
[21] FANG W,WEN X B,MENG Q S,et al.Running head:heat affects cholesterol and bile acid alterations in cholesterol and bile acids metabolism in large white pigs during short-term heat exposure[J].Animals (Basel),2020,10(2):359.
[22] BORGSTROEM B.Influence of bile salt,pH,and time on the action of pancreatic lipase;physiological implications[J].The Journal of Lipid Research,1964,5:522-531.
[23] WANG D Q H,TAZUMA S,COHEN D E,et al.Feeding natural hydrophilic bile acids inhibits intestinal cholesterol absorption:studies in the gallstone-susceptible mouse[J].American Journal of Physiology-Gastrointestinal and Liver Physiology,2003,285(3):G494-G502.
[24] TANAKA K,IKEDA I,SUGANO M.Effects of glyco- and tauro-cholic and chenodeoxycholic acids on lymphatic absorption of micellar cholesterol and sitosterol in rats[J].Bioscience,Biotechnology,and Biochemistry,1993,57(12):2059-2062.
[25] HOFMANN A F,RODA A.Physicochemical properties of bile acids and their relationship to biological properties:an overview of the problem[J].The Journal of Lipid Research,1984,25(13):1477-1489.
[26] WILSON F A,DIETSCHY J M.Characterization of bile acid absorption across the unstirred water layer and brush border of the rat jejunum[J].Journal of Clinical Investigation,1972,51(12):3015-3025.
[27] WATT S M,SIMMONDS W J.The specificity of bile salts in the intestinal absorption of micellar cholesterol in the rat[J].Clinical and Experimental Pharmacology and Physiology,1976,3(4):305-22.
[28] PIOMELLI D.A fatty gut feeling[J].Trends in Endocrinology & Metabolism,2013,24(7):332-341.
[29] MAGOTTI P,BAUER I,IGARASHI M,et al.Structure of human N-acylphosphatidylethanolamine-hydrolyzing phospholipase D:regulation of fatty acid ethanolamide biosynthesis by bile acids[J].Structure,2015,23(3):598-604.
[30] MARGHERITIS E,CASTELLANI B,MAGOTTI P,et al.Bile acid recognition by NAPE-PLD[J].ACS Chemical Biology,2016,11(10):2908-2914.
[31] ZENG H W,UMAR S,RUST B,et al.Secondary bile acids and short chain fatty acids in the colon:a focus on colonic microbiome,cell proliferation,inflammation,and cancer[J].International Journal of Molecular Sciences,2019,20(5):1214.
[32] TRABELSI M S,LESTAVEL S,STAELS B,et al.Intestinal bile acid receptors are key regulators of glucose homeostasis[J].Proceedings of the Nutrition Society,2017,76(3):192-202.
[33] DIMARZIO M,RUSCONI B,YENNAWAR N H,et al.Identification of a mouse
Lactobacillus johnsonii strain with deconjugase activity against the FXR antagonist T-β-MCA[J].PLoS One,2017,12(9):e0183564.
[34] DUBOC H,TACHÉ Y,HOFMANN A F.The bile acid TGR5 membrane receptor:from basic research to clinical application[J].Digestive and Liver Disease,2014,46(4):302-312.
[35] DEUTSCHMANN K,REICH M,KLINDT C,et al.Bile acid receptors in the biliary tree:TGR5 in physiology and disease[J].Biochimica et Biophysica Acta:Molecular Basis of Disease,2018,1864(4):1319-1325.
[36] WANG H B,CHEN J,HOLLISTER K,et al.Endogenous bile acids are ligands for the nuclear receptor FXR/BAR[J].Molecular Cell,1999,3(5):543-553.
[37] NOEL O F,STILL C D,ARGYROPOULOS G,et al.Bile acids,FXR,and metabolic effects of bariatric surgery[J].Journal of Obesity,2016,2016:4390254.
[38] SHAPIRO H,KOLODZIEJCZYK A A,HALSTUCH D,et al.Bile acids in glucose metabolism in health and disease[J].Journal of Experimental Medicine,2018,215(2):383-396.
[39] WATANABE M,HOUTEN S M,WANG L,et al.Bile acids lower triglyceride levels via a pathway involving FXR,SHP,and SREBP-1c[J].Journal of Clinical Investigation,2004,113(10):1408-1418.
[40] YAMAGATA K,DAITOKU H,SHIMAMOTO Y,et al.Bile acids regulate gluconeogenic gene expression via small heterodimer partner-mediated repression of hepatocyte nuclear factor 4 and Foxo1[J].The Journal of Biological Chemistry,2004,279(22):23158-23165.
[41] ZHANG Y Q,LEE F Y,BARRERA G,et al.Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice[J].Proceedings of the National Academy of Sciences of the United States of America,2006,103(4):1006-1011.
[42] SHIHABUDEEN M S,ROY D,JAMES J,et al.Chenodeoxycholic acid,an endogenous FXR ligand alters adipokines and reverses insulin resistance[J].Molecular and Cellular Endocrinology,2015,414:19-28.
[43] FANG S,SUH J M,REILLY S M,et al.Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance[J].Nature Medicine,2015,21(2):159-165.
[44] LI J B,LI T G.Bile acid receptors link nutrient sensing to metabolic regulation[J].Liver Research,2017,1(1):17-25.
[45] DE BOER J F,SCHONEWILLE M,BOESJES M,et al.Intestinal farnesoid X receptor controls transintestinal cholesterol excretion in mice[J].Gastroenterology,2017,152(5):1126-1138.
[46] MA K,SAHA P K,CHAN L,et al.Farnesoid X receptor is essential for normal glucose homeostasis[J].Journal of Clinical Investigation,2006,116(4):1102-1109.
[47] JIANG C T,XIE C,LV Y,et al.Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction[J].Nature Communications,2015,6:10166.
[48] XIE C,JIANG C T,SHI J M,et al.An intestinal farnesoid X receptor-ceramide signaling axis modulates hepatic gluconeogenesis in mice[J].Diabetes,2017,66(3):613-626.
[49] TRABELSI M S,DAOUDI M,PRAWITT J,et al.Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells[J].Nature Communications,2015,6:7629.
[50] WATANABE M,HORAI Y,HOUTEN S M,et al.Lowering bile acid pool size with a synthetic farnesoid X receptor (FXR) agonist induces obesity and diabetes through reduced energy expenditure[J].The Journal of Biological Chemistry,2011,286(30):26913-26920.
[51] VAN DIJK T H,GREFHORST A,OOSTERVEER M H,et al.An increased flux through the glucose 6-phosphate pool in enterocytes delays glucose absorption in
Fxr-/- mice[J].The Journal of Biological Chemistry,2009,284(16):10315-10323.
[52] CARON S,SAMANEZ C H,DEHONDT H,et al.Farnesoid X receptor inhibits the transcriptional activity of carbohydrate response element binding protein in human hepatocytes[J].Molecular and Cellular Biology,2013,33(11):2202-2211.
[53] ZEITZ U,WEBER K,SOEGIARTO D W,et al.Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor[J].The FASEB Journal,2003,17(3):509-511.
[54] OH J,RIEK A E,DARWECH I,et al.Deletion of macrophage vitamin D receptor promotes insulin resistance and monocyte cholesterol transport to accelerate atherosclerosis in mice[J].Cell Reports,2015,10(11):1872-1886.
[55] NI W,GLENN D J,GARDNER D G.Tie-2Cre mediated deletion of the vitamin D receptor gene leads to improved skeletal muscle insulin sensitivity and glucose tolerance[J].The Journal of Steroid Biochemistry and Molecular Biology,2016,164:281-286.
[56] NEHRING J A,ZIEROLD C,DELUCA H F.Lithocholic acid can carry out
in vivo functions of vitamin D[J].Proceedings of the National Academy of Sciences of the United States of America,2007,104(24):10006-10009.
[57] KAWAMATA Y,FUJⅡ R,HOSOYA M,et al.A G protein-coupled receptor responsive to bile acids[J].The Journal of Biological Chemistry,2003,278(11):9435-9440.
[58] THOMAS C,GIOIELLO A,NORIEGA L,et al.TGR5-mediated bile acid sensing controls glucose homeostasis[J].Cell Metabolism,2009,10(3):167-177.
[59] MORIMOTO K,WATANABE M,SUGIZAKI T,et al.Intestinal bile acid composition modulates prohormone convertase 1/3(PC1/3) expression and consequent GLP-1 production in male mice[J].Endocrinology,2016,157(3):1071-1081.
[60] ZHAI H N,LI Z,PENG M,et al.Takeda G protein-coupled receptor 5-mechanistic target of rapamycin complex 1 signaling contributes to the increment of glucagon-like peptide-1 production after Roux-en-Y gastric bypass[J].EBioMedicine,2018,32:201-214.
[61] LASALLE M,HOGUET V,HENNUYER N,et al.Topical intestinal aminoimidazole agonists of g-protein-coupled bile acid receptor 1 promote glucagon like peptide-1 secretion and improve glucose tolerance[J].Journal of Medicinal Chemistry,2017,60(10):4185-4211.
[62] KUHRE R E,ALBRECHTSEN N J W,LARSEN O,et al.Bile acids are important direct and indirect regulators of the secretion of appetite- and metabolism-regulating hormones from the gut and pancreas[J].Molecular Metabolism,2018,11:84-95.
[63] CAO H,CHEN Z X,WANG K,et al.Intestinally-targeted TGR5 agonists equipped with quaternary ammonium have an improved hypoglycemic effect and reduced gallbladder filling effect[J].Scientific Reports,2016,6:28676.
[64] PERINO A,POLS T W H,NOMURA M,et al.TGR5 reduces macrophage migration through mTOR-induced C/EBPβ differential translation[J].Journal of Clinical Investigation,2014,124(12):5424-5436.
[65] VELAZQUEZ-VILLEGAS L A,PERINO A,LEMOS V,et al.TGR5 signalling promotes mitochondrial fission and beige remodelling of white adipose tissue[J].Nature Communications,2018,9:245.
[66] WAHLSTRÖM A,SAYIN S I,MARSCHALL H U,et al.Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism[J].Cell Metabolism,2016,24(1):41-50.
[67] HAEUSLER R A,ASTIARRAGA B,CAMASTRA S,et al.Human insulin resistance is associated with increased plasma levels of 12α-hydroxylated bile acids[J].Diabetes,2013,62(12):4184-4191.
[68] CARIOU B,CHETIVEAUX M,ZAÏR Y,et al.Fasting plasma chenodeoxycholic acid and cholic acid concentrations are inversely correlated with insulin sensitivity in adults[J].Nutrition & Metabolism,2011,8:48.
[69] PATHAK P,CHIANG J Y L.Sterol 12α-hydroxylase aggravates dyslipidemia by activating the ceramide/mTORC1/SREBP-1C pathway via FGF21 and FGF15[J].Gene Expression,2019,19(3):161-173.
[70] CHIANG J Y L,FERRELL J M.Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy[J].American Journal of Physiology:Gastrointestinal and Liver Physiology,2020,318(3):G554-G573.
[71] HAEUSLER R A,PRATT-HYATT M,WELCH C L,et al.Impaired generation of 12-hydroxylated bile acids links hepatic insulin signaling with dyslipidemia[J].Cell Metabolism,2012,15(1):65-74.
[72] HIGUCHI S,AHMAD T R,ARGUETA D A,et al.Bile acid composition regulates GPR119-dependent intestinal lipid sensing and food intake regulation in mice[J].Gut,2020,69(9):1620-1628.
[73] DÜFER M,HÖRTH K,WAGNER R,et al.Bile acids acutely stimulate insulin secretion of mouse β-cells via farnesoid X receptor activation and K(ATP) channel inhibition[J].Diabetes,2012,61(6):1479-1489.
[74] KUMAR D P,ASGHARPOUR A,MIRSHAHI F,et al.Activation of transmembrane bile acid receptor TGR5 modulates pancreatic islet α cells to promote glucose homeostasis[J].The Journal of Biological Chemistry,2016,291(13):6626-6640.
[75] KURO-O M.The Klotho proteins in health and disease[J].Nature Reviews Nephrology,2019,15(1):27-44.
[76] SOMM E,JORNAYVAZ F R.Fibroblast growth factor 15/19:from basic functions to therapeutic perspectives[J].Endocrine Reviews,2018,39(6):960-989.
[77] POTTHOFF M J,BONEY-MONTOYA J,CHOI M,et al.FGF15/19 regulates hepatic glucose metabolism by inhibiting the CREB-PGC-1α pathway[J].Cell Metabolism,2011,13(6):729-738.
[78] KIR S,BEDDOW S A,SAMUEL V T,et al.FGF19 as a postprandial,insulin-independent activator of hepatic protein and glycogen synthesis[J].Science,2011,331(6024):1621-1624.
[79] LAN T,MORGAN D A,RAHMOUNI K,et al.FGF19,FGF21 and an FGFR1/β-klotho-activating antibody act on the nervous system to regulate body weight and glycemia[J].Cell Metabolism,2017,26(5):709-718.e3.
[80] LIU S M,MARCELIN G,BLOUET C,et al.A gut-brain axis regulating glucose metabolism mediated by bile acids and competitive fibroblast growth factor actions at the hypothalamus[J].Molecular Metabolism,2018,8:37-50.
[81] MARCELIN G,JO Y H,LI X S,et al.Central action of FGF19 reduces hypothalamic AGRP/NPY neuron activity and improves glucose metabolism[J].Molecular Metabolism,2014,3(1):19-28.
[82] FU L,JOHN L M,ADAMS S H,et al.Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetes[J].Endocrinology,2004,145(6):2594-2603.
[83] POTTHOFF M J,INAGAKI T,SATAPATI S,et al.FGF21 induces PGC-1α and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response[J].Proceedings of the National Academy of Sciences of the United States of America,2009,106(26):10853-10858.
[84] WU L W,MO W H,FENG J,et al.Astaxanthin attenuates hepatic damage and mitochondrial dysfunction in non-alcoholic fatty liver disease by up-regulating the FGF21/PGC-1α pathway[J].British Journal of Pharmacology,2020,177(16):3760-3777.
[85] HOLLAND W L,ADAMS A C,BROZINICK J T,et al.An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice[J].Cell Metabolism,2013,17(5):790-797.
[86] SCHOELER M,CAESAR R.Dietary lipids,gut microbiota and lipid metabolism[J].Reviews in Endocrine and Metabolic Disorders,2019,20(4):461-472.
[87] SONG Z W,CAI Y Y,LAO X Z,et al.Taxonomic profiling and populational patterns of bacterial bile salt hydrolase (
BSH) genes based on worldwide human gut microbiome[J].Microbiome,2019,7:9.
[88] GONZALEZ F J,JIANG C T,PATTERSON A D.An intestinal microbiota-farnesoid X receptor axis modulates metabolic disease[J].Gastroenterology,2016,151(5):845-859.
[89] QUINN R A,MELNIK A V,VRBANAC A,et al.Global chemical effects of the microbiome include new bile-acid conjugations[J].Nature,2020,579(7797):123-129.
[90] REIJNDERS D,GOOSSENS G H,HERMES G D A,et al.Effects of gut microbiota manipulation by antibiotics on host metabolism in obese humans:a randomized double-blind placebo-controlled trial[J].Cell Metabolism,2016,24(2):63-74.
[91] ZHANG Y C,LIMAYE P B,RENAUD H J,et al.Effect of various antibiotics on modulation of intestinal microbiota and bile acid profile in mice[J].Toxicology and Applied Pharmacology,2014,277(2):138-145.
[92] ABT M C,MCKENNEY P T,PAMER E G.
Clostridium difficile colitis:pathogenesis and host defence[J].Nature Reviews Microbiology,2016,14(10):609-620.
[93] WEI M L,HUANG F J,ZHAO L,et al.A dysregulated bile acid-gut microbiota axis contributes to obesity susceptibility[J].EBioMedicine,2020,55:102766.
[94] JIANG C T,XIE C,LI F,et al.Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease[J].Journal of Clinical Investigation,2015,125(1):386-402.
[95] ZHANG L M,XIE C,NICHOLS R G,et al.Farnesoid X receptor signaling shapes the gut microbiota and controls hepatic lipid metabolism[J].mSystems,2016,1(5):e00070-16.
[96] PARSÉUS A,SOMMER N,SOMMER F,et al.Microbiota-induced obesity requires farnesoid X receptor[J].Gut,2017,66(3):429-437.
[97] SUN L L,PANG Y Y,WANG X M,et al.Ablation of gut microbiota alleviates obesity-induced hepatic steatosis and glucose intolerance by modulating bile acid metabolism in hamsters[J].Acta Pharmaceutica Sinica B,2019,9(4):702-710.
[98] SUN L L,XIE C,WANG G,et al.Gut microbiota and intestinal FXR mediate the clinical benefits of metformin[J].Nature Medicine,2018,24(12):1919-1929.
[99] WATANABE M,HOUTEN S M,MATAKI C,et al.Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation[J].Nature,2006,439(7075):484-489.
[100] ANHÊ F F,NACHBAR R T,VARIN T V,et al.Treatment with camu camu (
Myrciaria dubia) prevents obesity by altering the gut microbiota and increasing energy expenditure in diet-induced obese mice[J].Gut,2019,68(3):453-464.
京公网安备 11010802041926号